Captor Therapeutics ®
News
November 13, 2025
CT-05 The Power of an Antibody in a Tablet
September 25, 2025
Beta-Catenin: An Elusive Target - New Chemistry as a Skeleton Key for Oncological Drugs
September 11, 2025
Captor reports MCL-1 Degraders: What Makes Them a Game-Changer? A New Era in the Fight Against Cancer
August 26, 2025
Captor Therapeutics in Communications Chemistry
May 21, 2025
New Hope in Liver Cancer Treatment – a Clinical Trial of the Innovative Drug CT-01 Has Been Initiated
February 17, 2025
Captor Therapeutics wins prestigious EIC Accelerator recommendation for funding of project CT-03
September 25, 2024
Captor Therapeutics Announces Clinical Candidate for Project CT-03!
August 23, 2024
Captor Therapeutics has applied for approval to conduct a Phase 1 clinical trial in Patients with Hepatocellular Carcinoma